144
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals

, , , , , & show all
Pages 679-689 | Published online: 21 Nov 2017

References

  • RiniBICampbellSCEscudierBRenal cell carcinomaLancet200937396691119113219269025
  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • FitzmauriceCDickerDPainAThe Global Burden of Cancer 2013JAMA Oncol20151450552726181261
  • JanzenNKKimHLFiglinRABelldegrunASSurveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent diseaseUrol Clin North Am200330484385214680319
  • MeskawiMSunMTrinhQDA review of integrated staging systems for renal cell carcinomaEur Urol201262230331422575911
  • ScholzenTGerdesJThe Ki-67 protein: from the known and the unknownJ Cell Physiol2000182331132210653597
  • LiedtkeCPackeisenJHessKRSystematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypesEur J Cancer201248132066207421920731
  • LuczynskaEGasinskaAWilkWExpression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancerPol J Pathol201263427227723359198
  • PanDWeiKLingYSuSZhuMChenGThe prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysisMed Sci Monit20152188288925807305
  • SkjulsvikAJMorkJNTorpMOTorpSHKi-67/MIB-1 immunostaining in a cohort of human gliomasInt J Clin Exp Pathol20147128905891025674263
  • ShiWHuJZhuSExpression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosisInt J Clin Exp Pathol2015810130831308926722504
  • Rioux-LeclercqNTurlinBBansardJValue of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinomaUrology200055450150510736491
  • OlumiAFWeidnerNPrestiJCp53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinomaUrol Oncol200162636711166623
  • YubaHOkamuraKOnoYOhshimaSGrowth fractions of human renal cell carcinoma defined by monoclonal antibody Ki-67. Predictive values for prognosisInte J Urol2001811609614
  • ChevilleJCZinckeHLohseCMpT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survivalCancer20029482180218412001115
  • BuiMHVisapaaHSeligsonDPrognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinomaJ Urol20041716 Pt 12461246615126876
  • KimHLSeligsonDLiuXUsing protein expressions to predict survival in clear cell renal carcinomaClin Cancer Res200410165464547115328185
  • LehmannJRetzMNurnbergNThe superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinomaCancer200410171552156215378494
  • YildizEGokceGKilicarslanHAyanSGozeOFGultekinEYPrognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinomaBJU Int20049371087109315142169
  • KimHLSeligsonDLiuXUsing tumor markers to predict the survival of patients with metastatic renal cell carcinomaJ Urol200517351496150115821467
  • KramerBAGaoXDavisMHallMHolzbeierleinJTawfikOPrognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinomaJ Am Coll Surg2005201456557016183495
  • KankuriMSoderstromKOPelliniemiTTVahlbergTPyrhonenSSalminenEThe association of immunoreactive p53 and Ki-67 with T-stage, grade, occurrence of metastases and survival in renal cell carcinomaAnticancer Res2006265B3825383317094408
  • PhuocNBEharaHGotohTImmunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinomaUrology200769584384817482919
  • TollefsonMKThompsonRHSheininYKi-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each otherCancer2007110478379017594714
  • GonteroPCerattiGGuglielmettiSPrognostic factors in a prospective series of papillary renal cell carcinomaBJU Int2008102669770218489525
  • ParkerASLeibovichBCLohseCMDevelopment and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinomaCancer2009115102092210319296514
  • ZubacDPBostadLKihlBSeidalTWentzel-LarsenTHaukaasSAThe expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survivalJ Urol200918252144214919758660
  • Kankuri-TammilehtoMKSoderstromKOPelliniemiTTVahlbergTPyrhonenSOSalminenEKPrognostic evaluation of COX-2 expression in renal cell carcinomaAnticancer Res20103073023303020683050
  • TomaMIWeberTMeinhardtMExpression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinomaCancer Invest201129212312921210727
  • WeberTMeinhardtMZastrowSWienkeAFuesselSWirthMPImmunohistochemical analysis of prognostic protein markers for primary localized clear cell renal cell carcinomaCancer Invest2013311515923327192
  • GayedBAYoussefRFBagrodiaAKi67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinomaBJU Int2014113466867323937277
  • TengJGaoYChenMPrognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinomaChin Med J201412791640164424791867
  • RautiolaJLampinenAMirttiTAssociation of angiopoietin-2 and Ki-67 expression with vascular density and sunitinib response in metastatic renal cell CarcinomaPLoS One2016114e015374527100185
  • VirmanJPBonoPLuukkaalaTHSunelaKLKujalaPMKellokumpu-LehtinenPLCombined angiogenesis and proliferation markers’ expressions as long-term prognostic factors in renal cell cancerClin Genitourin Cancer2016144e283e28926821530
  • LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationPLoS Med200967e10010019621070
  • StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
  • TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
  • StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) groupJAMA2000283152008201210789670
  • HandollHHSystematic reviews on rehabilitation interventionsArch Phys Med Rehabil200687687516731227
  • HigginsJPTThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
  • VisapaaHBuiMHuangYCorrelation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinomaUrology200361484585012670587
  • GerdesJSchwabULemkeHSteinHProduction of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInt J Cancer198331113206339421
  • SuttonAJSongFGilbodySMAbramsKRModelling publication bias in meta-analysis: a reviewStat Methods Med Res20009542144511191259